Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution

Table 2

Scale of measure for EZH2 expression in pediatric MDS.

Scale of expression level of EZH2	[0,1)	[1,3)	[3,13)
Defined groups	Low	Intermediate	High
Karyotypes	Monosomy 7 and del(7q)	Normal karyotypes	Trisomy 8 and del(11q)
Evolution MDS→AML (%)	100%	4.34%	63.63%

Notation in the form of [0,1) to indicate the numbers between 0 and 1; [1,3) to indicate the numbers between 1 and 3; [3,13) to indicate the numbers between 3 and 13.